Skip to content

Clinical trials

Drug Resistant Epilepsy trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Drug Resistant Epilepsy Country / region: Belgium Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20184
20192
20212
20221
20232
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Recruiting2
Unknown status2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biohaven Therapeutics Ltd.3
Cliniques universitaires Saint-Luc- Université Catholique de Louvain3
UCB Biopharma SRL2
University Hospital, Ghent2
KU Leuven1
LivaNova1
MedtronicNeuro1
Neuroelectrics Corporation1
Synergia Medical1
UCB Biopharma S.P.R.L.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Drug Resistant Epilepsy16
Epilepsy9
Seizures8
Epilepsies, Partial3
Epilepsy, Absence1
Epilepsy, Generalized1
Epilepsy, Tonic-Clonic1
Myoclonic Epilepsy, Juvenile1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.